e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Two new NKX2-1 mutations associated with pediatric interstitial lung diseases
L. Guillot, A. Carré, S. Gabor, E. Tron, C. Mireille, F. Delphine, C. Annick, P. Michel, E. Ralph (Paris, Basel, France; Paris, Switzerland)
Source:
Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Session:
What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Session type:
E-Communication Session
Number:
4767
Disease area:
Interstitial lung diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Guillot, A. Carré, S. Gabor, E. Tron, C. Mireille, F. Delphine, C. Annick, P. Michel, E. Ralph (Paris, Basel, France; Paris, Switzerland). Two new NKX2-1 mutations associated with pediatric interstitial lung diseases. Eur Respir J 2009; 34: Suppl. 53, 4767
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion: respiratory care for newborns in resource-limited settings
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Role of
ABCA3
in paediatric interstitial lung disease associated with surfactant protein C gene mutations
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009
Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3
G964A
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005
Interstitial lung disease in patients with connective tissue diseases - a report of 3 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
Interstitial lung diseases in infants and children
Source: Eur Respir J 2008; 31: 658-666
Year: 2008
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs)
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017
Year: 2017
Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
Homeobox-genes (HOX) in human lung - altered expression in lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001
The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept